| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0142(19940915)74:6<1693::AID-CNCR2820740609>3.0.CO;2-# |
| P698 | PubMed publication ID | 7915963 |
| P2093 | author name string | S O'Briain | |
| K Hickey | |||
| T N Walsh | |||
| T P Hennessy | |||
| I M Reid | |||
| D Grehan | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
| squamous cell carcinoma | Q681817 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1693-1698 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy | |
| P478 | volume | 74 |
| Q53913904 | Biological Behavior of Mucoepidermoid Carcinoma of the Esophagus |
| Q36563677 | Cancer of the gastroesophageal junction: Current therapy options |
| Q37198622 | Chemoradiotherapy for esophageal cancer. |
| Q37973690 | Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer |
| Q42860072 | Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors |
| Q34390923 | Early response evaluation and prediction in neoadjuvant-treated patients with esophageal cancer |
| Q44234506 | Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy. |
| Q43194164 | Esophageal cancer chemotherapy: recent advances. |
| Q35987242 | Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma |
| Q79522451 | Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome |
| Q36619645 | Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus |
| Q37777088 | Molecular Response Prediction in Multimodality Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction |
| Q34993237 | Molecular and biologic basis of upper gastrointestinal malignancy--esophageal carcinoma |
| Q33875652 | Molecular biology of esophageal squamous cell carcinoma |
| Q34224839 | Molecular markers predictive of response to chemotherapy in gastrointestinal tumors. |
| Q36341551 | Neoadjuvant chemotherapy for oesophageal cancer: the need for accurate response prediction and evaluation |
| Q40481566 | Oesophageal cancer: On the threshold of hope |
| Q73707399 | Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness? |
| Q26777898 | Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review |
| Q36022348 | Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation |
| Q78250638 | Preoperative chemotherapy for advanced esophageal cancer and relation with histological effect |
| Q73624732 | Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial |
| Q41520527 | Prognostic Factors in Esophageal Cancer |
| Q36921566 | Quinazoline derivatives: synthesis and bioactivities |
| Q44437207 | Selective separation of active inhibitors of epidermal growth factor receptor from Caragana Jubata by molecularly imprinted solid-phase extraction |
| Q40702060 | Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles: analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agents |
| Q38672374 | Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer |
| Q39584855 | The interaction between the Drosophila secreted protein argos and the epidermal growth factor receptor inhibits dimerization of the receptor and binding of secreted spitz to the receptor |
| Q36610597 | The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus. |
Search more.